Europe's Third-Largest Stock Exchange Lists Bitcoin ETP | BTCMANAGER

Germany-based Deutsche Boerse –Europe’s third-largest stock exchange – has officially accepted 21Shares’ Bitcoin exchange-traded product (ETP) and is now set to list the product on Xetra electronic trading platform, according to reports on July 1, 2020. Bitcoin ETP Live on Deutsche Boerse  While authorities in the United States are still pondering on whether to approve Bitcoin ETPs or not, European […]

Read more

Are Reports of Grayscale Gobbling up the Bitcoin Supply Exaggerated?

Reports have surfaced that Grayscale Investments is buying more Bitcoin than can be mined. According to a recent 8-K filing with the SEC, in a one week period, Grayscale added 19,879 BTC to its assets under management. One block is produced every 10 minutes, post halving each block now produces 12.5 BTC. Therefore, the average daily rate of production is […]

Read more

Only 27% of Circulating Bitcoin has Moved in 2020; Why This Matters

Bitcoin’s ongoing bout of sideways trading has offered little insight into its mid-term outlook. New data now shows that Bitcoin’s price action throughout 2020 has been driven by a significantly limited number of market participants, which may explain why the crypto has been ranging between $9,000 and $10,000 for over six weeks. According to one analytics firm, only 27% of […]

Read more

Symantec Thwarts Ransomware Attacks Against At Least 31 U.S. Corporations

Cybersecurity firm Symantec, a part of Broadcom, Inc., has claimed to have thwarted ransomware attacks against at least 31 U.S. corporations, including 11 listed companies, eight of which are Fortune 500 companies. It identified and alerted these customers about the attackers attempt to deploy the WastedLocker ransomware on their networks. Symantec identifies WastedLocker as a relatively new breed of targeted […]

Read more

FDA Snubs HRTX Again, ICPT Disappoints, KNSA Hits Right Notes, Is The Writing On The Wall For VRCA?

Today’s Daily Dose brings you news about Akero’s near-term catalyst; FDA denying approval to Heron’s HTX-011 for the management of postoperative pain and Intercept’s OCA for treatment of NASH; Kiniksa’s RHAPSODY trial results, PDS Biotechnology’s KOL meeting and regulatory update on Verrica’s VP-102. Read on… 1. Akero To Shed More Light On BALANCED Study Akero Therapeutics Inc. (AKRO) is all […]

Read more

Why Top Traders Expect Bitcoin to Hit $13,000 Despite Short-Term Weakness

Bitcoin appears to be incredibly weak from a short-term perspective. After breaking below $9,000 for a short period earlier this week, the crypto is once again at risk of breaking below the lower boundary of its long-held trading range. Multiple top traders, however, remain firmly bullish on the cryptocurrency’s mid-term price action. Some are even noting that they are anticipating […]

Read more
1 2 3 281